News search
Research 3 Nov 2022 CNIC scientists have identified a molecular mechanism that accounts for the arrhythmias, skeletal muscle weakness, and periodic paralysis in patients with this rare disease |
About the CNIC 2 Nov 2022 A new study defines a mechanism that regulates inflammation after a myocardial infarction, opening a path to the use of the receptor |
Research 3 Oct 2022 Metoprolol, an established drug in the cardiologists armory, protects the brain during a stroke and greatly reduces its consequences |
About the CNIC 19 Sep 2022 CNIC's leader have been recognized for his exceptional career achievements at the 34th annual conference |
Research 12 Sep 2022 The findings, published in the Journal of the American College of Cardiology (JACC), will enable physicians to make appropriate treatment adjustments for patients with this disease |
Research 29 Aug 2022 The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease |
Research 26 Aug 2022 The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM |
About the CNIC 23 Aug 2022 The finding provides a basis for mitigating the loss of muscle regenerative capacity in elderly people |
Research 9 Aug 2022 A new study published in eLife shows that inhibition of p38γ/δ is a potential therapeutic strategy for the treatment of hypertrophic cardiomyopathy, but that this strategy has yet to be explored because of the lack of specific inhibitors for these p38 family members |
Research 29 Jun 2022 Investigadores del CNIC revelan por primera los mecanismos moleculares que subyacen a las arritmias que ocurren en pacientes que padecen “Distrofia Muscular de Duchenne” |
- ‹ previous
- 7 of 32
- next ›